A Structure That Connects Research Outcomes to Industrial Sites
The center of gravity in the regional natural products industry is shifting away from individual research efforts or one-time events, toward a model in which local support institutions connect corporate demand with external research resources. Cases involving the Jecheon Foundation for Oriental Medicine and Natural Products Industry Promotion, the Korea Bioinformation Center (KOBIC), and the Namwon Bioindustry Foundation show a movement to speed up commercialization by tying material discovery, data utilization, and product development strategies into a single flow.
Behind this change is the judgment that natural product development can no longer remain competitive through traditional knowledge or individual experiments alone. Academic collaboration centered on an agriculture and life sciences-specialized large language model and the National Institute of Food and Drug Safety Evaluation is functioning as a foundation that helps researchers find evidence more quickly and systematize efficacy and safety reviews from the outset.
Regions First Building Standardization and Production Bases
Local governments and research institutes are focusing on the fact that bottlenecks in the natural products industry lie in inconsistent raw materials and unstable supply. The standardization hub development project and the development of a new variety of Trichosanthes suggest efforts to secure uniform raw materials that companies can use immediately by managing components and productivity from the cultivation stage onward.
This trend is also leading to infrastructure expansion that reduces the burden on small and medium-sized enterprises. Shared use of testing and analytical equipment through facilities such as an open laboratory lowers the barrier to entry for raw material verification and quality control, creating conditions in which regional companies can also participate in the competition for standardization.
Proving the Functionality of Domestic Materials and Converting Them into Products
Domestic medicinal crops are being reinterpreted beyond simple raw material supply, as functional ingredients tailored to specific health areas. Cases involving a mixed extract of Korean angelica and astragalus and a Stachys sieboldii extract show the process of translating traditionally used plants into the language of the health functional food market through clinical and preclinical evidence, patents, and technology transfer.
In this process, the key is not claims of efficacy but proof of reproducible quality. Even high-value natural materials that once relied mainly on sensory evaluation are moving toward data-based verification, as seen in the quantitative analysis of eudesmol in agarwood, which means stronger justification for premium pricing and greater ability to respond to regulation at the same time.
Rising Verification Pressure Alongside Growth Expectations
Some regions and companies are pursuing relocation of production bases and expansion of overseas sales channels through initiatives such as a 30 billion won investment agreement and an 800 million won cosmetics export contract, but market conditions are becoming increasingly demanding. In particular, ginseng exports fell sharply to US$61.7 million, revealing that regional relocation or export expansion is not simple growth but a survival strategy in response to cost pressures and market slowdown.
At the same time, as the industry grows, management gaps are becoming more visible. Controversies over the effectiveness of the harmful food blocking list and the process of recognizing the purchase performance of 27 tons of domestically produced cnidium highlight the need to establish trust first in distribution control, origin verification, and institutional enforcement, rather than focusing solely on growth itself in the natural products and health functional food market.